New Approach From Real World Evidence To Reduce Residual Risk In Cardiometabolic Disease 14 Aug 2021 14:00 14:50

Sponsored by Abbott Pharmaceuticals
Dr Ma Soot Keng Speaker
Dr Kisheaan Devarajan Chairperson

You can view the video ONLY if you are logged in. Click here to login